A detailed history of Baldwin Brothers LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Baldwin Brothers LLC holds 104 shares of MRNA stock, worth $4,386. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104
Previous 104 -0.0%
Holding current value
$4,386
Previous $12,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023

SELL
$118.38 - $210.04 $30,660 - $54,400
-259 Reduced 71.35%
104 $0
Q1 2022

Apr 13, 2022

BUY
$126.46 - $235.05 $3,667 - $6,816
29 Added 8.68%
363 $63,000
Q3 2021

Oct 27, 2021

SELL
$221.9 - $484.47 $39,054 - $85,266
-176 Reduced 34.51%
334 $129,000
Q4 2020

Jan 12, 2021

SELL
$65.74 - $169.86 $26,295 - $67,944
-400 Reduced 43.96%
510 $53,000
Q3 2020

Oct 16, 2020

BUY
$54.34 - $94.85 $43,472 - $75,880
800 Added 727.27%
910 $64,000
Q4 2019

Jan 29, 2020

BUY
$13.93 - $21.28 $1,532 - $2,340
110 New
110 $2,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Baldwin Brothers LLC Portfolio

Follow Baldwin Brothers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.